TY - JOUR
T1 - Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults
T2 - A Meta-analysis
AU - Ahuja, Vasudha
AU - Aronen, Pasi
AU - Pramodkumar, T. A.
AU - Looker, Helen
AU - Chetrit, Angela
AU - Bloigu, Aini H.
AU - Juutilainen, Auni
AU - Bianchi, Cristina
AU - La Sala, Lucia
AU - Anjana, Ranjit Mohan
AU - Pradeepa, Rajendra
AU - Venkatesan, Ulagamadesan
AU - Jebarani, Sarvanan
AU - Baskar, Viswanathan
AU - Fiorentino, Teresa Vanessa
AU - Timpel, Patrick
AU - DeFronzo, Ralph A.
AU - Ceriello, Antonio
AU - Del Prato, Stefano
AU - Abdul-Ghani, Muhammad
AU - Keinänen-Kiukaanniemi, Sirkka
AU - Dankner, Rachel
AU - Bennett, Peter H.
AU - Knowler, William C.
AU - Schwarz, Peter
AU - Sesti, Giorgio
AU - Oka, Rie
AU - Mohan, Viswanathan
AU - Groop, Leif
AU - Tuomilehto, Jaakko
AU - Ripatti, Samuli
AU - Bergman, Michael
AU - Tuomi, Tiinamaija
N1 - Publisher Copyright:
© 2021 by the American Diabetes Association.
PY - 2021/4/1
Y1 - 2021/4/1
N2 - OBJECTIVE: One-hour plasma glucose (1-h PG) during the oral glucose tolerance test (OGTT) is an accurate predictor of type 2 diabetes. We performed a meta-analysis to determine the optimum cutoff of 1-h PG for detection of type 2 diabetes using 2-h PG as the gold standard. RESEARCH DESIGN AND METHODS: We included 15 studies with 35,551 participants from multiple ethnic groups (53.8% Caucasian) and 2,705 newly detected cases of diabetes based on 2-h PG during OGTT. We excluded cases identified only by elevated fasting plasma glucose and/or HbA1c. We determined the optimal 1-h PG threshold and its accuracy at this cutoff for detection of diabetes (2-h PG ≥11.1 mmol/L) using a mixed linear effects regression model with different weights to sensitivity/specificity (2/3, 1/2, and 1/3). RESULTS: Three cutoffs of 1-h PG, at 10.6 mmol/L, 11.6 mmol/L, and 12.5 mmol/L, had sensitivities of 0.95, 0.92, and 0.87 and specificities of 0.86, 0.91, and 0.94 at weights 2/3, 1/2, and 1/3, respectively. The cutoff of 11.6 mmol/L (95% CI 10.6, 12.6) had a sensitivity of 0.92 (0.87, 0.95), specificity of 0.91 (0.88, 0.93), area under the curve 0.939 (95% confidence region for sensitivity at a given specificity: 0.904, 0.946), and a positive predictive value of 45%. CONCLUSIONS: The 1-h PG of ≥11.6 mmol/L during OGTT has a good sensitivity and specificity for detecting type 2 diabetes. Prescreening with a diabetes-specific risk calculator to identify high-risk individuals is suggested to decrease the proportion of false-positive cases. Studies including other ethnic groups and assessing complication risk are warranted.
AB - OBJECTIVE: One-hour plasma glucose (1-h PG) during the oral glucose tolerance test (OGTT) is an accurate predictor of type 2 diabetes. We performed a meta-analysis to determine the optimum cutoff of 1-h PG for detection of type 2 diabetes using 2-h PG as the gold standard. RESEARCH DESIGN AND METHODS: We included 15 studies with 35,551 participants from multiple ethnic groups (53.8% Caucasian) and 2,705 newly detected cases of diabetes based on 2-h PG during OGTT. We excluded cases identified only by elevated fasting plasma glucose and/or HbA1c. We determined the optimal 1-h PG threshold and its accuracy at this cutoff for detection of diabetes (2-h PG ≥11.1 mmol/L) using a mixed linear effects regression model with different weights to sensitivity/specificity (2/3, 1/2, and 1/3). RESULTS: Three cutoffs of 1-h PG, at 10.6 mmol/L, 11.6 mmol/L, and 12.5 mmol/L, had sensitivities of 0.95, 0.92, and 0.87 and specificities of 0.86, 0.91, and 0.94 at weights 2/3, 1/2, and 1/3, respectively. The cutoff of 11.6 mmol/L (95% CI 10.6, 12.6) had a sensitivity of 0.92 (0.87, 0.95), specificity of 0.91 (0.88, 0.93), area under the curve 0.939 (95% confidence region for sensitivity at a given specificity: 0.904, 0.946), and a positive predictive value of 45%. CONCLUSIONS: The 1-h PG of ≥11.6 mmol/L during OGTT has a good sensitivity and specificity for detecting type 2 diabetes. Prescreening with a diabetes-specific risk calculator to identify high-risk individuals is suggested to decrease the proportion of false-positive cases. Studies including other ethnic groups and assessing complication risk are warranted.
UR - http://www.scopus.com/inward/record.url?scp=85103231563&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103231563&partnerID=8YFLogxK
U2 - 10.2337/dc20-1688
DO - 10.2337/dc20-1688
M3 - Article
C2 - 33741697
AN - SCOPUS:85103231563
SN - 1935-5548
VL - 44
SP - 1062
EP - 1069
JO - Diabetes care
JF - Diabetes care
IS - 4
ER -